Radial artery occlusion following angiography.
Conditions
Interventions
Intervention 1: Intervention group: The patients in the study group were treated with apixaban (2.5 mg every 12 hours, orally, manufactured by Abidi Co.) for 28 days, and after the end of the treatmen
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: People who have undergone radial artery angiography Symptoms related to radial artery occlusion (such as pain and palpable radial pulse) Confirmed by Doppler imaging
Exclusion criteria
Exclusion criteria: Lack of patient satisfaction The need for a therapeutic dose of anticoagulants The use of other anticoagulants Severe symptoms of vascular occlusion that require rapid intervention to restore the arterial channel Contraindications for apixaban use include severe drug sensitivity Active clinical and pathological bleeding such as gastrointestinal and cerebral hemostasis disorder and advanced renal failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Radial artery occlusion. Timepoint: Before the intervention and 28 days after the intervention. Method of measurement: The inclusion criteria are people who have undergone radial artery angiography and then have symptoms related to radial artery occlusion (such as pain and palpable radial pulse), which can be confirmed by Doppler imaging. All ultrasounds are performed by a radiologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Afshin Amirpour
Esfahan University of Medical Sciences
Outcome results
None listed